1 year return (CAGR)
-
Neuphoria Therapeutics Inc Exchange (NASDAQ, USD)
NEUP
3.68
-0.03 (-0.81%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
19.89M
Price/Sales
-
Ent value
5.83M
Price/Book
0.68
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
18.12%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.69 |
| Daily high | 3.75 |
| Daily low | 3.66 |
| Daily Volume | 15K |
| All-time high | 20.00 |
| 1y analyst estimate | 7.00 |
| Beta | - |
| EPS (TTM) | -5.09 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NEUP | S&P500 | |
| Current price drop from All-time high | -81.60% | -1.29% |
| Highest price drop | -83.50% | -56.47% |
| Date of highest drop | 20 Jul 2026 | 9 Mar 2009 |
| Avg drop from high | -72.99% | -10.68% |
| Avg time to new high | 36 days | 12 days |
| Max time to new high | 243 days | 1805 days |
News
